{
    "organizations": [],
    "uuid": "e57dc6c80d7fa7db560b3e9460dd93baadec8031",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-pulse-biosciences-announces-positi/brief-pulse-biosciences-announces-positive-results-from-its-first-study-evaluating-a-clinical-target-at-major-scientific-meeting-idUSFWN1RP12O",
    "ord_in_thread": 0,
    "title": "Pulse Biosciences Announces Positive Results From Its First Study Evaluating A Clinical Target At Major Scientific Meeting",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 12 (Reuters) - Pulse Biosciences Inc:\n* PULSE BIOSCIENCES ANNOUNCES POSITIVE RESULTS FROM ITS FIRST STUDY EVALUATING A CLINICAL TARGET AT MAJOR SCIENTIFIC MEETING\n* AN INDEPENDENT, BLINDED PHOTOGRAPHIC REVIEW OF LESION IMAGES SCORED 71% OF LESIONS AS CLEAR OR MOSTLY CLEAR IN TRIAL\n* PATIENTS RATED 78% OF LESION OUTCOMES AS SATISFIED OR MOSTLY SATISFIED, CLOSELY MIRRORING INVESTIGATOR RATINGS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-13T05:24:00.000+03:00",
    "crawled": "2018-04-13T00:27:09.012+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "pulse",
        "bioscience",
        "inc",
        "pulse",
        "bioscience",
        "announces",
        "positive",
        "result",
        "first",
        "study",
        "evaluating",
        "clinical",
        "target",
        "major",
        "scientific",
        "meeting",
        "independent",
        "blinded",
        "photographic",
        "review",
        "lesion",
        "image",
        "scored",
        "lesion",
        "clear",
        "mostly",
        "clear",
        "trial",
        "patient",
        "rated",
        "lesion",
        "outcome",
        "satisfied",
        "mostly",
        "satisfied",
        "closely",
        "mirroring",
        "investigator",
        "rating",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}